Cutting edge

A new tool to evaluate human pre-erythrocytic malaria vaccines: Rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein

Cathrine Persson, Giane A. Oliveira, Ali Sultan, Purnima Bhanot, Victor Nussenzweig, Elizabeth Nardin

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Malaria vaccines containing the Plasmodium falciparum Circumsporozoite protein repeat domain are undergoing human trials. There is no simple method to evaluate the effect of vaccine-induced responses on P. falciparum sporozoite infectivity. Unlike the rodent malaria Plasmodium berghei, P. falciparum sporozoites do not infect common laboratory animals and only develop in vitro in human hepatocyte cultures. We generated a recombinant P. berghei parasite bearing P. falciparum Circumsporozoite protein repeats. These hybrid sporozoites are fully infective in vivo and in vitro. Monoclonal and polyclonal Abs to P. falciparum repeats neutralize hybrid parasite infectivity, and mice immunized with a P. falciparum vaccine are protected against challenge with hybrid sporozoites.

Original languageEnglish
Pages (from-to)6681-6685
Number of pages5
JournalJournal of Immunology
Volume169
Issue number12
Publication statusPublished - 15 Dec 2002
Externally publishedYes

Fingerprint

Malaria Vaccines
Plasmodium falciparum
Sporozoites
Rodentia
Parasites
Plasmodium berghei
Vaccines
Laboratory Animals
Malaria
Hepatocytes
Protozoan circumsporozoite protein

ASJC Scopus subject areas

  • Immunology

Cite this

Cutting edge : A new tool to evaluate human pre-erythrocytic malaria vaccines: Rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein. / Persson, Cathrine; Oliveira, Giane A.; Sultan, Ali; Bhanot, Purnima; Nussenzweig, Victor; Nardin, Elizabeth.

In: Journal of Immunology, Vol. 169, No. 12, 15.12.2002, p. 6681-6685.

Research output: Contribution to journalArticle

Persson, Cathrine ; Oliveira, Giane A. ; Sultan, Ali ; Bhanot, Purnima ; Nussenzweig, Victor ; Nardin, Elizabeth. / Cutting edge : A new tool to evaluate human pre-erythrocytic malaria vaccines: Rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein. In: Journal of Immunology. 2002 ; Vol. 169, No. 12. pp. 6681-6685.
@article{f73c9920ea18473aa9789b4c0c6e78f1,
title = "Cutting edge: A new tool to evaluate human pre-erythrocytic malaria vaccines: Rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein",
abstract = "Malaria vaccines containing the Plasmodium falciparum Circumsporozoite protein repeat domain are undergoing human trials. There is no simple method to evaluate the effect of vaccine-induced responses on P. falciparum sporozoite infectivity. Unlike the rodent malaria Plasmodium berghei, P. falciparum sporozoites do not infect common laboratory animals and only develop in vitro in human hepatocyte cultures. We generated a recombinant P. berghei parasite bearing P. falciparum Circumsporozoite protein repeats. These hybrid sporozoites are fully infective in vivo and in vitro. Monoclonal and polyclonal Abs to P. falciparum repeats neutralize hybrid parasite infectivity, and mice immunized with a P. falciparum vaccine are protected against challenge with hybrid sporozoites.",
author = "Cathrine Persson and Oliveira, {Giane A.} and Ali Sultan and Purnima Bhanot and Victor Nussenzweig and Elizabeth Nardin",
year = "2002",
month = "12",
day = "15",
language = "English",
volume = "169",
pages = "6681--6685",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Cutting edge

T2 - A new tool to evaluate human pre-erythrocytic malaria vaccines: Rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein

AU - Persson, Cathrine

AU - Oliveira, Giane A.

AU - Sultan, Ali

AU - Bhanot, Purnima

AU - Nussenzweig, Victor

AU - Nardin, Elizabeth

PY - 2002/12/15

Y1 - 2002/12/15

N2 - Malaria vaccines containing the Plasmodium falciparum Circumsporozoite protein repeat domain are undergoing human trials. There is no simple method to evaluate the effect of vaccine-induced responses on P. falciparum sporozoite infectivity. Unlike the rodent malaria Plasmodium berghei, P. falciparum sporozoites do not infect common laboratory animals and only develop in vitro in human hepatocyte cultures. We generated a recombinant P. berghei parasite bearing P. falciparum Circumsporozoite protein repeats. These hybrid sporozoites are fully infective in vivo and in vitro. Monoclonal and polyclonal Abs to P. falciparum repeats neutralize hybrid parasite infectivity, and mice immunized with a P. falciparum vaccine are protected against challenge with hybrid sporozoites.

AB - Malaria vaccines containing the Plasmodium falciparum Circumsporozoite protein repeat domain are undergoing human trials. There is no simple method to evaluate the effect of vaccine-induced responses on P. falciparum sporozoite infectivity. Unlike the rodent malaria Plasmodium berghei, P. falciparum sporozoites do not infect common laboratory animals and only develop in vitro in human hepatocyte cultures. We generated a recombinant P. berghei parasite bearing P. falciparum Circumsporozoite protein repeats. These hybrid sporozoites are fully infective in vivo and in vitro. Monoclonal and polyclonal Abs to P. falciparum repeats neutralize hybrid parasite infectivity, and mice immunized with a P. falciparum vaccine are protected against challenge with hybrid sporozoites.

UR - http://www.scopus.com/inward/record.url?scp=0037114136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037114136&partnerID=8YFLogxK

M3 - Article

VL - 169

SP - 6681

EP - 6685

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -